Literature DB >> 16054942

Treatment of menopausal symptoms: what shall we do now?

Martha Hickey1, Susan R Davis, David W Sturdee.   

Abstract

During the past few years, many women and doctors have revised their opinions of hormone replacement therapy (HRT) for menopausal symptoms, and a substantial number of individuals have discontinued its use because of concerns about side-effects. Numerous alternatives to HRT are promoted, and assessment of the quality of evidence about the safety and effectiveness of these compounds can be difficult. In this Review, we summarise the data from studies addressing the efficacy, risks, and benefits of frequently prescribed treatments, and offer evidence-based clinical guidelines for the management of menopausal symptoms. Although few comparative studies exist, oestrogen alone or combinations of oestrogen and progestagen are likely to be the most effective treatments for menopausal hot flushes and vaginal dryness. Tibolone is as effective as HRT, however, and might also improve libido. For those who wish to avoid hormonal treatments, there are few effective options. Selective serotonin reuptake inhibitors might be effective in the very short term (less than 12 weeks) and are well tolerated. There is not enough evidence that any of the complementary therapies available are any better than placebo for menopausal vasomotor symptoms, and few safety data exist.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054942     DOI: 10.1016/S0140-6736(05)66519-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

1.  Estrogen implants: embodiments of deeper problems in the marketing of drugs.

Authors:  Gordon Schiff; Judy Norsigian
Journal:  J Gen Intern Med       Date:  2010-09       Impact factor: 5.128

Review 2.  Current breast cancer risks of hormone replacement therapy in postmenopausal women.

Authors:  Nirav R Shah; Tanping Wong
Journal:  Expert Opin Pharmacother       Date:  2006-12       Impact factor: 3.889

Review 3.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 4.  Managing the menopause.

Authors:  Helen Roberts
Journal:  BMJ       Date:  2007-04-07

5.  Determinants of willingness to pay for a new therapy in a sample of menopausal-aged women.

Authors:  Andrej Rasch; Jan-Marc Hodek; Claus Runge; Wolfgang Greiner
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

6.  Effect of black cohosh (cimicifuga racemosa) on vasomotor symptoms in postmenopausal women: a randomized clinical trial.

Authors:  Mahnaz Shahnazi; Jila Nahaee; Sakineh Mohammad-Alizadeh-Charandabi; Somaye Bayatipayan
Journal:  J Caring Sci       Date:  2013-06-01

Review 7.  Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.

Authors:  Susan Furness; Helen Roberts; Jane Marjoribanks; Anne Lethaby
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

8.  Iron sensitizes keratinocytes and fibroblasts to UVA-mediated matrix metalloproteinase-1 through TNF-α and ERK activation.

Authors:  Jinlong Jian; Edward Pelle; Qing Yang; Nadine Pernodet; Daniel Maes; Xi Huang
Journal:  Exp Dermatol       Date:  2011-03       Impact factor: 3.960

9.  Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.

Authors:  Agnès Fournier; Franco Berrino; Françoise Clavel-Chapelon
Journal:  Breast Cancer Res Treat       Date:  2007-02-27       Impact factor: 4.872

10.  The effects of postmenopausal hormone therapy on social activity, partner relationship, and sexual life - experience from the EPHT trial.

Authors:  Elina Hemminki; Piret Veerus; Heti Pisarev; Sirpa-Liisa Hovi; Päivi Topo; Helle Karro
Journal:  BMC Womens Health       Date:  2009-06-08       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.